REQUEST A DEMO
Total
USD $0.00
Search more companies

Pontus Pharma d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pontus Pharma d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pontus Pharma d.o.o. is a company in Croatia, with a head office in Zagreb. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Pontus Pharma d.o.o. was incorporated on January 13, 2026. 18 (2024) employees currently work for Pontus Pharma d.o.o.. From the latest financial highlights, Pontus Pharma d.o.o. reported a net sales revenue increase of 55.1% in 2024. Its’ total assets recorded a growth of 11.82%. The net profit margin of Pontus Pharma d.o.o. decreased by 0.38% in 2024.

Headquarters
Kralja Zvonimira 62 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Pontus Pharma d.o.o. report to view the information.

Website: http://www.pontus-pharma.com

Basic Information
Total Employees:
Purchase the Pontus Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Pontus Pharma d.o.o. report to view the information.
Incorporation Date:
January 13, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Pontus Pharma D.O.O. Beograd (Serbia)
Company Performance
Financial values in the chart are available after Pontus Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
55.1%
Total operating revenue
55.1%
Operating profit (EBIT)
102.46%
EBITDA
167.29%
Net Profit (Loss) for the Period
4.66%
Total Assets
11.82%
Total Equity
953.02%
Operating Profit Margin (ROS)
0.57%
Net Profit Margin
-0.38%
Return on Equity (ROE)
-77.91%
Debt/Equity
-1609.85%
Quick Ratio
-0.03%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?